Cognitive and oculomotor performance in subjects with low and high schizotypy: implications for translational drug development studies

The development of drugs to improve cognition in patients with schizophrenia is a major unmet clinical need. A number of promising compounds failed in recent clinical trials, a pattern linked to poor translation between preclinical and clinical stages of drug development. Seeking proof of efficacy i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Transl Psychiatry
Päätekijät: Koychev, I, Joyce, D, Barkus, E, Ettinger, U, Schmechtig, A, Dourish, C T, Dawson, G R, Craig, K J, Deakin, J F W
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2016
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070057/
https://ncbi.nlm.nih.gov/pubmed/27187233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tp.2016.64
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia